|
|
|
This is the preliminary program for the 2009 Joint Statistical
Meetings in Washington, DC.
|
|
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2009 Program page |
= Applied Session,
= Theme Session,
= Presenter
446
|
Wed, 8/5/09, 10:30 AM - 12:20 PM | CC-202B |
| Statistics in Biopharmaceutical Research: Novel Approaches to Designing Adaptive Clinical Trials - Invited - Papers | ||
|
Statistics in Biopharmaceutical Research Journal, Biopharmaceutical Section |
||
| Organizer(s): Joseph Heyse, Merck Research Laboratories | ||
| Chair(s): Joseph Heyse, Merck Research Laboratories | ||
| 10:35 AM |
Flexible Phase I Clinical Trials: Allowing for Nonbinary Toxicity Response and Removal of Other Common Limitations —  Richard F. Potthoff, Duke University Medical Center; Stephen L. George, Duke University Medical Center
|
|
| 11:00 AM |
T-Statistic-Based Up and Down Design for Dose-Finding Competes Favorably with Bayesian 4-Parameter Logistic Design — James A. Bolognese, Cytel, Inc.; Nitin R. Patel, Cytel, Inc.; Yevgen Tymofyeyef, Merck & Co., Inc.; Inna Perevozskaya, Merck & Co., Inc.; Jeffrey Palmer, Cytel, Inc.
|
|
| 11:25 AM |
Adaptive Dose-Finding in Non-Life-Threatening Diseases: Review and Case Studies — Anastasia Ivanova, The University of North Carolina at Chapel Hill
|
|
| 11:50 AM |
Variance-Based Sample Size Reassessment Increases Relative Efficiency of Studies — Deepak B. Khatry, MedImmune, LLC
|
|
| 12:15 PM | Floor Discussion | |
|
JSM 2009
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |